Psilocybin-Research.comSearchable psilocybin and psilocin bibliometric database.Authors in the psilocybin and psilocin literature
Search researcher names, inspect publication history, find recurring topics, and create author watch alerts without collecting unverified contact lists.
Publication history
No evidence for deleterious effects of psilocybin and MDMA on working memory or related neurophysiological activity in a non-clinical population: An uncontrolled exploratory study.Journal of Psychopharmacology · 2026-07-22Longitudinal neural and psychological changes following psilocybin under compassion imagery primingFrontiers in Human Neuroscience · 2026-07-21Classic psychedelics and personality: An updated systematic reviewJournal of Psychopharmacology · 2026-05-30Rapid-acting interventions in treatment-resistant depression - a comparative review of esketamine and psilocybinJournal of Pre-Clinical and Clinical Research · 2026-05-11Complete biosynthesis of psychedelic tryptamines from three kingdoms in plantsScience Advances · 2026-03-31Associations Between Psilocybin Use Motives and Cognitive, Affective, and Behavioural Self-StigmaSubstance Use & Misuse · 2026-03-27Psychedelic Experiences and Finitude in Serious Illness: A Qualitative SynthesisJournal of Pain and Symptom Management · 2026-03-26Psychedelics for treatment of negative symptoms and depressive symptoms in schizophrenia spectrum disorder: A narrative reviewSchizophrenia Research · 2026-03-12Development and assessment of a psychedelic-assisted therapy music playlist for clinical trials: Theory, intentionality, and metricsJournal of Psychedelic Studies · 2026-02-11Participant Experiences of Therapeutic Touch in Psilocybin-Assisted TherapyBrain and Behavior · 2026-01-31The Use of Psilocybin in the Treatment of Depressive Disorders: A Narrative ReviewCureus · 2026-01-30Pharmacological Management of Anxiety in End-of-Life Care: A Systematic Review of Benzodiazepines, Opioids, and PsilocybinHuman Psychopharmacology Clinical and Experimental · 2025-12-31Psilocybin in the real world: Regulatory, ethical, and operational challenges in Australia’s clinical landscapeAustralian & New Zealand Journal of Psychiatry · 2025-12-163642 Down the rabbit hole: case reports of a hallucinogen-induced disorder of neuroperceptionUnknown journal · 2025-09-30Psilocybin-assisted psychotherapy for methamphetamine use disorder: A pilot open-label safety and feasibility studyAddiction · 2025-09-19Psilocybin with psychotherapeutic support for treatment-resistant depression: a pilot clinical trialTherapeutic Advances in Psychopharmacology · 2025-08-31Psilocybin in alcohol use disorder and comorbid depressive symptoms: Results from a feasibility randomized clinical trialAddiction · 2025-07-23Stronger visual surround suppression under psilocybin: A psychophysical and EEG pilot studyJournal of Vision · 2025-07-14Exploring the Frontiers of Psychedelics: A New Chromatographic Method for Detection and Quantification of Psilocybin and Psilocin in Psilocybe cubensis MushroomsACS Omega · 2025-07-09Effects of Psilocin and Psilocybin on Human 5-HT4 Serotonin and H2 Histamine Receptors in Perfused Hearts of Transgenic MicePharmaceuticals · 2025-07-05Exploring the integration of psychedelic-assisted therapy and digital mental health interventions in trauma recovery for underserved adults with high-functioning autismMagna Scientia Advanced Research and Reviews · 2025-06-2758. Acute Behavioral Effects of Psilocybin and Its Pharmacokinetics in Nonhuman PrimatesBiological Psychiatry · 2025-04-08Psilocybin Dispensaries and Advertising-Buyer BewareJAMA Network Open · 2025-03-31Risks of using psilocybin in treatment of treatment-resistant depressionJournal of Education Health and Sport · 2025-03-05Esse quam Videre: Critical Reflections on the Use of Psilocybin as an Adjuvant in Psychedelic-Assisted PsychotherapyPolymatheia. · 2025-02-14The Acceptability of Psychedelic-Assisted Therapy Amongst Mental Health Consumers: Utilising the Theory of Planned BehaviourInternational Journal of Mental Health Nursing · 2025-01-31Effects of Psilocybin on Mouse Brain MicrostructureAmerican Journal of Neuroradiology · 2025-01-28PSYCHEDELICS IN THE TREATMENT OF MENTAL DISORDERSHealth and Society · 2025-01-07High-quality draft genomes of ecologically and geographically diverse Psilocybe speciesMicrobiology Resource Announcements · 2024-12-26The many faces of psilocybin-related psychosis: A case seriesPsychiatry Research Case Reports · 2024-12-06Prospective Preference Assessment for the Psilocybin for Enhanced Analgesia in Chronic nEuropathic PAIN (PEACE-PAIN) TrialCanadian Journal of Pain · 2024-11-07Enhanced visual contrast suppression during peak psilocybin effects: Psychophysical results from a pilot randomized controlled trialJournal of Vision · 2024-11-04Australian psychologists' attitudes towards psychedelic-assisted therapy and training following a world-first drug down-schedulingDrug and Alcohol Review · 2024-11-04“The mushroom was more alive and vibrant”: Patient reports of synthetic versus organic forms of psilocybinJournal of Psychedelic Studies · 2024-10-28The Action on Psilocybin in Neural Plasticity, Brain Reorganization and Cognitive EnhancementMiddle East Research Journal of Biological Sciences · 2024-09-27Psilocybin-induzierte mystische Erfahrungen in subjektiven Berichten: Ein Scoping Review mit qualitativer Inhaltsanalyse.Suchttherapie · 2024-08-31Psilocybin, peyote, mescaline, and lysergic acid diethylamide (LSD) use in a nationally representative population by cancer history.Journal of Clinical Oncology · 2024-05-31The ‘PSILAUT’ protocol: an experimental medicine study of autistic differences in the function of brain serotonin targets of psilocybinBMC Psychiatry · 2024-04-24Genetic regulation of l-tryptophan metabolism in Psilocybe mexicana supports psilocybin biosynthesisFungal Biology and Biotechnology · 2024-04-24The psychedelic call: analysis of Australian Poisons Information Centre calls associated with classic psychedelicsClinical Toxicology · 2024-04-01Exploring the molecular basis of treatment-resistant depression: Discoveries from a rat model and psilocybin therapyNeuroscience Applied · 2023-12-31Established sensitization of ethanol-induced locomotor activity is not reversed by psilocybin or the 5-HT2A receptor agonist TCB-2 in male DBA/2J micePharmacology Biochemistry and Behavior · 2023-12-25Acceptability of psilocybin-assisted group therapy in patients with cancer and major depressive disorder: Qualitative analysisCancer · 2023-12-17Psilocybin-assisted group therapy in patients with cancer diagnosed with a major depressive disorderCancer · 2023-12-17Group psychedelic therapy: empirical estimates of cost-savings and improved accessFrontiers in Psychiatry · 2023-12-05Psilocybin for Opioid Use Disorder in Two Adults Stabilized on Buprenorphine: A Technical Report on Study Modifications and Preliminary FindingsPsychedelic Medicine · 2023-11-30Epidemiology of classic psychedelic substances: results from a Norwegian internet convenience sampleFrontiers in Psychiatry · 2023-11-12Investigation of the structure, stability, and relative solubility of psilocybin in water and pure organic solvents: A molecular simulation studyJournal of Molecular Liquids · 2023-11-06Effects of psilocybin, the 5-HT2A receptor agonist TCB-2, and the 5-HT2A receptor antagonist M100907 on visual attention in male mice in the continuous performance testPsychopharmacology · 2023-10-18Psychedelics as Therapeutics: Research Advances and Implications for PracticeJournal of the American Academy of Child & Adolescent Psychiatry · 2023-09-30Self-perception and self-recognition while looking in the mirror on psilocybinJournal of Psychedelic Studies · 2023-09-18Repeated low doses of psilocybin increase resilience to stress, lower compulsive actions, and strengthen cortical connections to the paraventricular thalamic nucleus in ratsMolecular Psychiatry · 2023-08-31Single-Dose Psilocybin Treatment for Major Depressive DisorderJAMA · 2023-08-30Developing a Direct Observation Measure of Therapeutic Connection in Psilocybin-Assisted Therapy: A Feasibility StudyJournal of Palliative Medicine · 2023-08-16HOPE: A Pilot Study of Psilocybin Enhanced Group Psychotherapy in Patients With CancerJournal of Pain and Symptom Management · 2023-06-09Cost-effectiveness of psilocybin-assisted therapy for severe depression: exploratory findings from a decision analytic modelPsychological Medicine · 2023-06-01Long term efficacy of psilocybin in patients with cancer and major depressive disorder (MDD).Journal of Clinical Oncology · 2023-05-31Study protocol of an open-label proof-of-concept trial examining the safety and clinical efficacy of psilocybin-assisted therapy for veterans with PTSDBMJ Open · 2023-04-30Assessment of Psilocybin Therapy for Patients With Cancer and Major Depression DisorderJAMA Oncology · 2023-04-12509. Meta-Analysis of Functional Neuroimaging Studies of the Effects of Serotonergic Psychedelics on Neural ActivityBiological Psychiatry · 2023-04-09The Effects of Serotonergic Psychedelics on Neural Activity: A Meta-Analysis of Task-Based Functional Neuroimaging StudiesEuropean Psychiatry · 2023-02-28Group format psychedelic-assisted therapy interventions: Observations and impressions from the HOPE trialJournal of Psychedelic Studies · 2023-01-17DNA Authentication and Chemical Analysis of Psilocybe Mushrooms Reveal Widespread Misdeterminations in Fungaria and Inconsistencies in MetabolitesApplied and Environmental Microbiology · 2022-11-28Single-Dose Psilocybin for a Treatment-Resistant Episode of Major Depression.New England Journal of Medicine · 2022-10-31Insights for Modern Applications of Psilocybin Therapy from a Case Study of Traditional Mazatec MedicineAnthropology of Consciousness · 2022-08-13Psilocybin reduces low frequency oscillatory power and neuronal phase-locking in the anterior cingulate cortex of awake rodents.Scientific Reports · 2022-07-25Psilocybin microdosers demonstrate greater observed improvements in mood and mental health at one month relative to non-microdosing controlsVIUspace · 2022-06-29Psilocybin microdosers demonstrate greater observed improvements in mood and mental health at one month relative to non-microdosing controls.Scientific Reports · 2022-06-29The safety and efficacy of psilocybin therapy in patients with cancer and major depressive disorder.Journal of Clinical Oncology · 2022-05-31Critique of the Royal Australian and New Zealand College of Psychiatrists Psychedelic Therapy Clinical Memorandum, Dated May 2020Journal of Medical and Health Studies · 2021-12-30Announcement of two special issues: behavioural pharmacology of synaptopathies and psychedelic drugsBehavioural Pharmacology · 2021-12-12P.0729 Highlights of psychedelic history and current research on psilocybin application for treatment of depression - a comprehensive literature reviewEuropean Neuropsychopharmacology · 2021-11-30Adults who microdose psychedelics report health related motivations and lower levels of anxiety and depression compared to non-microdosers.Scientific Reports · 2021-11-17Psilocybin targets a common molecular mechanism for cognitive impairment and increased craving in alcoholism.Science Advances · 2021-11-16Effects of psilocybin-assisted therapy on treatment-resistant depressionEuropean Psychiatry · 2021-03-31Medicinal psychedelics for mental health and addiction: Advancing research of an emerging paradigm.Australian & New Zealand Journal of Psychiatry · 2021-03-20Psilocybin im Dorsch Lexikon der PsychologieUnknown journal · 2020-12-31How ecstasy and psilocybin are shaking up psychiatry.Nature · 2020-12-31Advancing elite athlete mental health treatment with psychedelic-assisted psychotherapyJournal of Applied Sport Psychology · 2020-11-09Perceived harm, motivations for use and subjective experiences of recreational psychedelic ‘magic’ mushroom useJournal of Psychopharmacology · 2020-07-16Scoping Review Protocol: Mapping Psilocybin Therapy ResearchUnknown journal · 2020-05-19Exposure-Response Analysis to Assess the Concentration-QTc Relationship of Psilocybin/PsilocinClinical Pharmacology in Drug Development · 2020-04-05Psilocybin-assisted therapy for depression: How do we advance the field?Australian & New Zealand Journal of Psychiatry · 2019-11-21Dynamical exploration of the repertoire of brain networks at rest is modulated by psilocybinNeuroImage · 2019-05-23Denver votes to decriminalise psilocybin mushroomsThe Lancet · 2019-04-30Psychedelic Medicine: Careful Studies, Regulations Are the AnswerPsychiatric News · 2019-04-29High dose psilocybin is associated with positive subjective effects in healthy volunteers.Journal of Psychopharmacology · 2018-06-26Psilocybin and MDMA reduce costly punishment in the Ultimatum Game.Scientific Reports · 2018-05-28Pharmacokinetics of Escalating Doses of Oral Psilocybin in Healthy Adults.Clinical Pharmacokinetics · 2017-11-30Psilocybin and Mescaline - Molecule of the Month October 1999 [Archived version]Bristol Research (University of Bristol) · 2017-07-25Psilocybin and Mescaline - Molecule of the Month October 1999 [Archived version]Open MIND · 2016-12-31Homological scaffolds of brain functional networks.Journal of The Royal Society Interface · 2014-11-30Molecule of the Month: Psilocybin and MescalineUnknown journal · 1999-09-30Ethnopharmacology of ska María Pastora (Salvia divinorum, Epling and Játiva-M.).Unknown journal · 1983-04-30Molecular structures of hallucinogenic substances: lysergic acid diethylamide, psilocybin, and 2,4,5-trimethoxyamphetamine.Unknown journal · 1972-12-31The relationship of carbon and nitrogen nutrition of Psilocybe baeocystis to the production of psilocybin and its analogs.Unknown journal · 1969-02-28Baeocystin and norbaeocystin: new analogs of psilocybin from Psilocybe baeocystis.Unknown journal · 1968-09-30Baeocystin, a mono-methyl analog of psilocybin from Psilocybe baeocystis saprophytic culture.Unknown journal · 1966-12-31Production of Psilocybin in Psilocybe baeocystis Saprophytic CultureJournal of Pharmaceutical Sciences · 1965-10-31Comparison of three psychotropic drugs (psilocybin, JB-329, and IT-290) in volunteer subjects.Unknown journal · 1960-10-31